Rethinking Drug Costs: Trump's Bold Bid to Reshape Pharmaceutical Pricing
The Great Pharma Debate: Which Giant Will Dominate Your Portfolio?
Pharma's Big Win: How a Judge's Ruling Ignited Big Pharma Stocks
Unpacking the Final Trades: GDX, Pfizer, GlobalFoundries, and Bristol Myers Squibb Under the Microscope
The Enduring Battle: Trump, Pfizer, and the Shifting Tides of Prescription Drug Pricing
The Pharmaceutical Tsunami: How a Second Trump Term Could Reshape Drug Pricing, Medicare, and Vaccines
Transatlantic Tremors: How US Drug Pricing Reforms Are Reshaping the Global Pharmaceutical Landscape
President Trump Unveils Landmark Deals: Slashing Drug Costs and Boosting COVID-19 Testing
America's Crossroads: Military Overhauls, Economic Shifts, and Unfolding Dramas
A Pharmaceutical Powerhouse Pivots: Pfizer Embraces Trump's 'Most Favored Nation' Pricing
TrumpRx Unveils Groundbreaking Platform to Dramatically Cut Prescription Drug Costs
Game Changer: Pfizer Secures Tariff Reprieve, Vows Lower Drug Prices for Millions of Americans
A Landmark Deal: Pfizer Slashes Drug Costs for Medicaid Patients in Trump Administration Agreement
Pfizer's Bold New Chapter: Shares Soar as Pharma Giant Commits to Sweeping US Drug Price Cuts
TrumpRx Unleashes Massive 85% Discounts on Pfizer Drugs: A Game Changer?
The "TrumpRx" Initiative: A Disruptive Force in the Pharmaceutical Landscape, Challenging Giants Like Pfizer
Trump Hails Landmark Pfizer Deal: $70 Million US Investment and Drug Price Cuts Announced
Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs
Trump Hails "Historic" Deal with Pfizer to Drastically Cut Drug Prices
Trump's Bold Move: White House Pressures Pharma Giants for Lower Drug Prices
Unpacking the Market's Pulse: From Pharma Politics to Robotic Deliveries and the Fed's Inflation Fight
The Silent Scourge? Women Link Popular Birth Control Shot to Debilitating Brain Tumors
Get Protected: Updated COVID-19 Vaccines Now Widely Available Without a Prescription!
Market Movers: Decoding Final Trades for Apple, Citi, Pfizer, and Kenvue Ahead
Pfizer's Pivotal Leap: BMO Analyst Seigerman Declares Bullish Outlook on Long-Awaited Obesity Market Entry via Metsara Deal
Pfizer's Bold Gambit: Unlocking the Future of Obesity Treatment with Metsera and Oral GLP-1s
Pfizer's Colossal $4.9 Billion Bet: A Game-Changer in the Obesity Treatment Arena
Pfizer's Bold Gambit: Unleashing New Weapons in the Global Battle Against Obesity
Pfizer's Bold Leap: Eyeing Metsara in Blockbuster Acquisition Bid
Pharma Giants Stumble: CDC Plan to Add COVID-19 Vaccines to Childhood Schedule Sparks Market Jitters
From ResearchStart to Pfizer: Callie Miller's Inspiring Scientific Journey
Breakthrough Protection: Pfizer-BioNTech's Next-Gen COVID-19 Vaccine Unveils Robust Immune Defense Against Evolving Threats
Navigating the Headwinds: Pfizer and BioNTech's mRNA Vaccine Forecast Adjusted
Sanofi Stock Plunges as Zantac Lawsuit Risks Re-Emerge Following Key Judicial Ruling
Trump Unleashes Scrutiny: Demands Pfizer and COVID Drug Makers 'Show Their Results' Amidst New FDA Clampdown
Trump Unleashes Scathing Critique on Pharma Giants Over COVID-19 Vaccines and Profits
Spring Renewal: CDC Recommends Additional COVID-19 Boosters for Key Groups
Boost Your Defense: New Guidelines for Updated COVID-19 Vaccine Eligibility Revealed
Spring Into Protection: CDC Updates COVID-19 Vaccine Guidance for Vulnerable Groups
The Waiting Game: Why Your Updated COVID Vaccine Might Be Hard to Find
Expert's Urgent Call: COVID-19 Remains a Serious Threat Even as New Fall Vaccines Arrive
Canada's New Line of Defense: Updated COVID-19 Vaccines Approved for Fall
FDA Greenlights Latest Pfizer COVID-19 Vaccine to Combat Omicron Subvariant